Skip to the page

Data / Form D filings / Nostopharma, LLC

Nostopharma, LLC: Form D filings

Nostopharma, LLC, a health care company in Potomac, MD, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on September 26, 2024, reports $250,000 sold of a $250,000 offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
5 Greenlane Court, Potomac, MD, 20854
Phone
(240) 997-5073
Industry
Other Health Care
Entity type
Limited Liability Company
Incorporated in
Maryland
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1981853

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 26, 2024New notice$250,000$250,0001Sep 11, 2024sec.gov
Jun 21, 2023New notice$250,000$250,0001Jun 7, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Ekaterina Vert-WongExecutive Officer, Director
Jelena Gvozdenovic-JeremicExecutive Officer

Other health care companies in Maryland that filed recently

Every Form D from the week of Sep 23, 2024 · All recent filings in Maryland · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Nostopharma, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.